We are live on ! Find out more
MBOT icon

Microbot Medical
MBOT

27 hedge funds and large institutions have $4.65M invested in Microbot Medical in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

0% more funds holding

Funds holding: 27 → 27 (0)

1.01% less ownership

Funds ownership: 11.43% → 10.43% (-1%)

24% less capital invested

Capital invested by funds: $6.1M → $4.65M (-$1.45M)

67% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 6

Holders
27
Holders Change
–
Holders Change %
0%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
2
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$87K
2
Millennium Management
Millennium Management
New York
+$82K
3
BAM
Blueshift Asset Management
New Jersey
+$75.2K
4
CAN
Cetera Advisor Networks
California
+$72.9K
5
Renaissance Technologies
Renaissance Technologies
New York
+$31.6K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$95K
2
IMA
Investment Management Associates
Colorado
-$75K
3
State Street
State Street
Massachusetts
-$55.7K
4
Northern Trust
Northern Trust
Illinois
-$8.49K
5
BlackRock
BlackRock
New York
-$5.63K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.69M – – –
BlackRock
2
BlackRock
New York
$971K -$5.63K -961 -0.6%
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$582K – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$316K – – –
Morgan Stanley
5
Morgan Stanley
New York
$240K +$20.4K +3,486 +10%
State Street
6
State Street
Massachusetts
$158K -$55.7K -9,500 -27%
Bank of New York Mellon
7
Bank of New York Mellon
New York
$98K – – –
Renaissance Technologies
8
Renaissance Technologies
New York
$98K +$31.6K +5,400 +52%
Citadel Advisors
9
Citadel Advisors
Florida
$93K +$87K +14,847 New
Millennium Management
10
Millennium Management
New York
$88K +$82K +13,997 New
BAM
11
Blueshift Asset Management
New Jersey
$81K +$75.2K +12,841 New
CAN
12
Cetera Advisor Networks
California
$78K +$72.9K +12,448 New
SPIA
13
Steward Partners Investment Advisory
New York
$73K – – –
Northern Trust
14
Northern Trust
Illinois
$65K -$8.49K -1,449 -12%
TRCT
15
Tower Research Capital (TRC)
New York
$7K +$6.52K +1,112 New
NSIM
16
North Star Investment Management
Illinois
$4K – – –
Wells Fargo
17
Wells Fargo
California
$1K -$6 -1 -0.4%
Osaic Holdings
18
Osaic Holdings
Arizona
$1K – – –
PFGIA
19
Patriot Financial Group Insurance Agency
Massachusetts
$1K – – –
VF
20
Virtu Financial
New York
– -$95K -12,622 Closed
IMA
21
Investment Management Associates
Colorado
– -$75K -10,000 Closed
Royal Bank of Canada
22
Royal Bank of Canada
Ontario, Canada
– -$3.51K -599 -100%
RI
23
Rinkey Investments
California
– -$3K -500 Closed
CA
24
CoreCap Advisors
Michigan
– -$1K -50 Closed
Bank of America
25
Bank of America
North Carolina
– -$64 -11 -73%
1
2

MBOT Hedge Fund Activity: Q1 2022 in Review

27 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q1 2022, worth a combined $4.65M — down 24% from $6.1M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new MBOT positions and 5 closed out — a net gain of 1 holder — while 2 added to existing stakes and 6 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $87K. The largest seller was Virtu Financial, exiting entirely with an estimated $95K sold.

  • 27 institutional investors held Microbot Medical (MBOT) as of Q1 2022, unchanged from Q4 2021.
  • Funds reported $4.65M of Microbot Medical stock for Q1 2022, down 24% quarter-over-quarter.
  • 6 funds opened new Microbot Medical positions in Q1 2022 and 5 closed out, a net change of +1 holder.
  • The largest Microbot Medical buyer in Q1 2022 was Citadel Advisors, an estimated $87K added.
  • The largest Microbot Medical seller in Q1 2022 was Virtu Financial, an estimated $95K sold.

Based on aggregated 13F filings for Q1 2022.